Page last updated: 2024-09-05

serrawettin w2 and Leukemia, Promyelocytic, Acute

serrawettin w2 has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

*Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cai, X; Han, T; He, Q; Li, A; Qiu, H; Shen, L; Xiao, Y; Zhang, P1

Other Studies

1 other study(ies) available for serrawettin w2 and Leukemia, Promyelocytic, Acute

ArticleYear
Genome-driven discovery of new serrawettin W2 analogues from
    Organic & biomolecular chemistry, 2023, 11-22, Volume: 21, Issue:45

    Topics: Escherichia coli; Humans; Leukemia, Promyelocytic, Acute; Peptides, Cyclic; Serratia

2023